Alerts will be sent to your verified email
Verify EmailAMRUTANJAN
|
Amrutanjan Health.
|
Health X Platform
|
Max India
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
R&D as a % of Total Sales
|
0.3 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
14.67 % | 15.4 % | 0.0 |
|
5yr average Equity Multiplier
|
1.41 | 1.51 | 1.48 |
|
5yr Average Asset Turnover Ratio
|
1.22 | 1.11 | 0.23 |
|
5yr Avg Net Profit Margin
|
8.57 % | 16.57 % | -36.69 % |
|
Price to Book
|
4.26 | 1.51 | 2.04 |
|
P/E
|
27.26 | 822.85 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
21.59 Days | n/a | -241.58 Days |
|
Inventory Days
|
23.18 Days | n/a | 254.38 Days |
|
Days Receivable
|
51.48 Days | n/a | 34.05 Days |
|
Days Payable
|
49.13 Days | n/a | 217.2 Days |
|
5yr Average Interest Coverage Ratio
|
27.21 | n/a | -5.5 |
|
5yr Avg ROCE
|
24.07 % | n/a | -7.4 % |
|
5yr Avg Operating Profit Margin
|
14.15 % | n/a | -27.3 % |
|
5 yr average Debt to Equity
|
0.12 | n/a | 0.06 |
|
5yr CAGR Net Profit
|
16.38 % | n/a | 22.16 % |
|
5yr Average Return on Assets
|
10.59 % | n/a | -7.77 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
46.52 % | 74.84 % | 49.82 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-3.52 % | 0.92 % | -1.29 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.1 % | 0.0 | 0.0 |
|
Amrutanjan Health.
|
Health X Platform
|
Max India
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
|
Brand Wise Break-Up
|
Brand Wise Break-Up
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|